Connection
Colin Anderson to Disease Models, Animal
This is a "connection" page, showing publications Colin Anderson has written about Disease Models, Animal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.110 |
|
|
|
-
Sawada K, Oates JR, Kimura M, Stankiewicz TE, Eom J, Alarcon PC, Chung H, Damen MSMA, Ulanowicz CJ, Wayland JL, Williams Fonner ESO, Anderson CC, Cuervo-Jimenez HK, Pearson AM, Wang Y, Salomonis N, Troutman TD, Reisz JA, Rathmell JC, Szabo S, Helmrath MA, Takebe T, Moreno-Fernandez ME, Divanovic S. Glutamine metabolism as a rheostat of CD4+ T cell pathogenic function in metabolic dysfunction-associated steatotic liver disease. Cell Metab. 2026 Oct 06; 38(10):2090-2110.e9.
Score: 0.028
-
Budnick I, Argabright A, Anderson CC, Bevers S, Okamura K, He Z, Reisz JA, Baker PR, Montford J, Faubel S. Plasma metabolomics analysis in murine prerenal azotemia reveals changes in energy substrates, amino acid metabolism, and uremic toxins. Am J Physiol Renal Physiol. 2026 06 01; 330(6):F683-F701.
Score: 0.028
-
Li AS, Baker PR, Park S, Budnick I, He Z, Okamura K, Gil HW, Miyazaki M, Anderson CC, Reisz JA, Faubel S. Metabolomic assessment reveals depletion of amino acids and energy metabolites in skeletal muscle after ischemic acute kidney injury in mice. Sci Rep. 2026 Feb 13; 16(1).
Score: 0.027
-
Ghosh S, Devereaux MW, Anderson AL, Anderson CC, D'Alessandro A, Orlicky DJ, Sokol RJ. Dietary Lauric Acid Suppresses Inflammation, Cholestasis, Hepatocyte Injury, and Senescence in 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine-induced Inflammatory Cholangiopathy. Cell Mol Gastroenterol Hepatol. 2026; 20(5):101731.
Score: 0.027
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|